Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

SHA:605077 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	942.08	434.21	2,128	1,040	1,244	248.78
Short-Term Investments	-	583.66	461.79	387.5	-	-
Trading Asset Securities	260.02	0.03	0.18	0.22	70.05	-
Cash & Short-Term Investments	1,202	1,018	2,590	1,428	1,314	248.78
Cash Growth	168.74%	-60.70%	81.38%	8.72%	427.99%	41.99%
Accounts Receivable	735.46	769.01	500.31	392.94	242.55	173.6
Other Receivables	11.85	26.7	6.05	8.14	14.58	9.5
Receivables	747.31	795.71	506.37	401.08	257.13	183.1
Inventory	640.99	697.39	282.04	279.06	199.74	151.41
Other Current Assets	668.9	64.21	36.16	29.87	32.23	16
Total Current Assets	3,259	2,575	3,415	2,138	1,803	599.3
Property, Plant & Equipment	3,706	3,588	1,844	1,355	991.3	704.18
Long-Term Investments	75.77	93.49	94.42	122.53	58.56	53.46
Goodwill	346.16	346.16	346.16	26.11	26.11	-
Other Intangible Assets	299.71	305.87	282.65	242.46	90.06	55.19
Long-Term Deferred Tax Assets	30.25	23.53	8.13	3.95	7.37	-
Long-Term Deferred Charges	31.43	35.13	17.29	11.14	12.54	11.4
Other Long-Term Assets	13.3	24.89	169.79	5.62	15.4	6.15
Total Assets	7,761	6,992	6,178	3,905	3,004	1,430
Accounts Payable	923.73	443.34	208.42	169.9	228.07	194.99
Accrued Expenses	45.07	122.64	88.55	71.24	41.37	35.98
Short-Term Debt	691.9	150.3	247.12	260.24	119.82	102.75
Current Portion of Long-Term Debt	209.39	226.64	171.65	39.74	-	-
Current Portion of Leases	-	0.95	0.56	1.24	-	-
Current Income Taxes Payable	42.68	37.1	32.34	-	-	20.86
Current Unearned Revenue	31.14	15.01	19.95	12.05	8.58	7.45
Other Current Liabilities	174.28	677.18	253.16	215.12	57.88	17.33
Total Current Liabilities	2,118	1,673	1,022	769.53	455.72	379.37
Long-Term Debt	2,188	1,859	1,868	345.46	20.02	51.17
Long-Term Leases	8.01	3.2	0.02	0.51	1.46	-
Long-Term Unearned Revenue	149.12	118.28	94.21	51.37	38.4	25.26
Long-Term Deferred Tax Liabilities	77.65	82.62	92.19	74.37	53.95	33.85
Other Long-Term Liabilities	-	-	-	8	-	0.5
Total Liabilities	4,541	3,737	3,077	1,249	569.56	490.16
Common Stock	303.05	305.88	234.61	228.46	163.18	87.42
Additional Paid-In Capital	1,424	1,441	1,479	1,405	1,470	170.98
Retained Earnings	1,319	1,363	1,257	1,023	801.28	681.13
Treasury Stock	-36.1	-61.99	-77.37	-	-	-
Comprehensive Income & Other	196.07	196.13	196.23	-0.01	-0.02	-0.01
Total Common Equity	3,206	3,243	3,089	2,656	2,434	939.52
Minority Interest	14.1	11.89	11.59	-	-	-
Shareholders' Equity	3,220	3,255	3,101	2,656	2,434	939.52
Total Liabilities & Equity	7,761	6,992	6,178	3,905	3,004	1,430
Total Debt	3,097	2,241	2,288	647.18	141.3	153.92
Net Cash (Debt)	-1,895	-1,223	302.51	780.96	1,172	94.87
Net Cash Growth	-	-	-61.26%	-33.38%	1135.67%	1278.18%
Net Cash Per Share	-5.86	-3.23	1.02	2.63	4.08	0.43
Filing Date Shares Outstanding	291.97	299.43	296.99	296.99	296.99	296.99
Total Common Shares Outstanding	291.97	299.43	296.99	296.99	296.99	222.75
Working Capital	1,141	902.05	2,393	1,369	1,347	219.93
Book Value Per Share	10.31	10.18	9.74	8.94	8.20	4.22
Tangible Book Value	2,560	2,591	2,461	2,387	2,318	884.33
Tangible Book Value Per Share	8.10	8.00	7.62	8.04	7.81	3.97
Buildings	-	1,014	576.89	429.74	336.07	250.13
Machinery	-	2,262	1,803	1,429	960.55	789.18
Construction In Progress	-	1,330	290.58	110.27	230.98	60.1

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.